한글목차

생검 기기 시장은 2025년에 25억 5,770만 달러로 추정되며, 2032년에는 39억 7,460만 달러에 달할 것으로 예측되며, 2025-2032년 CAGR은 6.5%로 성장할 것으로 예측됩니다.

생검은 장기나 종양의 조직이나 세포를 검사하여 질병을 진단하기 위해 시행하는 의료 시술입니다. 생검 기기는 신체 부위에서 조직 샘플을 채취하는 데 사용되는 최소 침습적 툴입니다. 생검 기기 세계 시장은 암 발병률 증가와 저침습적 진단 절차에 대한 수요 증가로 인해 괄목할 만한 성장세를 보이고 있습니다. 고령화 인구 증가, 질병의 조기 진단 및 치료에 대한 선호, 생검 기기의 개선으로 이어지는 기술 발전 등의 요인이 시장 확대에 기여하고 있습니다. 그러나 생검 시술에 따른 합병증과 새로운 생검 제품 승인에 대한 엄격한 규제 프레임워크와 같은 요인은 큰 도전이 될 수 있습니다. 전반적으로 생검 기기 시장은 질병의 조기 검진 및 진단에 대한 인식이 높아짐에 따라 예측 기간 중 안정적인 성장세를 보일 것으로 예측됩니다.

시장 역학

생검 기기 세계 시장은 주로 전 세계 암 발병률 증가에 의해 주도되고 있습니다. 만성질환의 위험 증가로 이어지는 생활 습관의 변화, 대상 질환에 취약한 노인 인구 증가, 저침습적 기술의 이점은 생검 절차에 대한 수요를 촉진하는 주요 요인입니다. 그러나 생검 기기와 관련된 높은 비용, 숙련된 전문가 부족, 생검 시술과 관련된 합병증은 시장 성장을 제한할 수 있습니다.

첨단 생검 툴 개발을 위한 지속적인 연구, 신흥 시장의 미개발 잠재력, 유리한 상환 시나리오는 새로운 기회를 제공합니다. 또한 주요 시장 진출기업의 혁신적인 제품 출시는 예측 기간 중 시장 개발을 촉진할 것으로 예측됩니다. 예를 들어 2022년 9월, 세계 헬스케어 기술의 선도적인 제조 및 유통업체인 Merit Medical Systems, Inc.는 미국에서 TEMNO Elite Soft Tissue Biopsy System의 상용 출시를 발표했습니다. 이 제품은 Merit의 다양한 생검 기기 제품군에 새롭게 추가된 제품입니다.

본 조사의 주요 특징

• 이 보고서는 2024년을 기준 연도로 하여 2025-2032년의 예측 기간 중 생검 기기 세계 시장 규모(USD Mn)와 연평균 성장률(CAGR%)을 상세하게 분석하여 시장 규모를 예측한 보고서입니다.
• 다양한 부문에 걸친 잠재적 매출 성장 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 인사이트을 제공합니다.
• 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 성과, 전략 등의 매개 변수를 기반으로 세계 생검 기기 시장의 주요 기업 개요을 제공합니다.
• 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 생검 기기 세계 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 생검 기기 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.

목차

제1장 조사의 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 리포트 설명
  • 시장의 정의와 범위
• 개요
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
• 신흥 경제국
• 혁신적인 생검 암 디바이스의 발매
• 저침습생검 기술의 개발
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 제품 발매/승인
• PEST 분석
• PORTER의 산업 분석
• 합병과 인수 시나리오

제4장 생검 기기 시장, 제품 유형별, 2020-2032년

• 시술 트레이
• 바늘 기반 생검 기구
• 액체 생검 기구
• 생검대
• 생검 겸자
• 기타

제5장 생검 기기 시장, 생검 유형별, 2020-2032년

• 골수 생검
• 원추 절제술
• 절제 생검
• 액체생검
• 침생검
• 기타

제6장 생검 기기 시장, 용도별, 2020-2032년

• 전립선
• 자궁내막
• 간
• 심장
• 기타

제7장 생검 기기 시장, 최종사용자별, 2020-2032년

• 병원과 진료소
• 진단 실험실
• 학술 조사기관

제8장 생검 기기 시장, 지역별, 2020-2032년

• 북미
  • 미국
  • 캐나다
• 유럽
  • 영국
  • 독일
  • 이탈리아
  • 프랑스
  • 스페인
  • 러시아
  • 기타 유럽
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • ASEAN
  • 호주
  • 한국
  • 기타 아시아태평양
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
  • 기타 라틴아메리카
• 중동
  • GCC
  • 이스라엘
  • 기타 중동
• 아프리카
  • 중앙아프리카
  • 남아프리카공화국
  • 북아프리카

제9장 경쟁 구도

• Merit Medical Systems, Inc
• Hologic, Inc.
• Becton, Dickinson and Company
• Medtronic plc
• Stryker Corporation
• Leica Biosystems Nussloch GmbH
• Gallini Srl
• TSK Laboratory
• Remicalm
• Meditech Devices
• Agilent Technologies Inc.
• Guardant Health, Inc.
• Agena Bioscience
• nRichDX
• Epic Sciences, Inc.
• Predicine, Inc.
• Argon Medical Devices
• Cook Medical
• Hologic Inc.
• Gallini Medical
• Intact Medical Corporation

제10장 섹션

• 조사 방법
• 출판사 소개

영문목차

Biopsy Devices Market is estimated to be valued at USD 2,557.7 Mn in 2025 and is expected to reach USD 3,974.6 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2032.

A biopsy is a medical procedure performed to diagnose diseases by examining the tissues or cells of organs or tumors. Biopsy devices are minimally invasive tools used to collect tissue samples from affected areas of the body. The global biopsy devices market has been witnessing tremendous growth, attributed to the rising incidence of cancer and increasing demand for minimally invasive diagnostic procedures. Factors such as a growing aging population, a preference for early disease diagnosis, and treatment and technological advancements leading to improved biopsy tools are contributing to market expansion. However, factors like complications associated with biopsy procedures and a strict regulatory framework for the approval of new biopsy products can present major challenges. Overall, with increased awareness about early screening and diagnosis of diseases, the biopsy devices market is expected to witness steady growth over the forecast period.

Market Dynamics

The global biopsy devices market is primarily driven by the increasing prevalence of cancer worldwide. Changing lifestyle habits leading to a rising risk of chronic diseases, a growing elderly population susceptible to targeted diseases, and the benefits offered by minimally invasive techniques are major factors fueling demand for biopsy procedures. However, high costs associated with biopsy devices, a dearth of skilled professionals, and complications pertaining to biopsy techniques can restrict market growth.

Ongoing research for the development of advanced biopsy tools, untapped potential in emerging markets, and favorable reimbursement scenarios present new opportunities. In addition, the launch of innovative products by key market players is anticipated to drive the market development over the forecast period. For instance, in September 2022, Merit Medical Systems, Inc., a leading global manufacturer and marketer of healthcare technology, announced the commercial release of the TEMNO Elite Soft Tissue Biopsy System in the U.S., the latest addition to Merit's extensive line of biopsy devices.

Key features of the study

• This report provides an in-depth analysis of the global biopsy devices market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global biopsy devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Merit Medical Systems, Inc, Hologic, Inc., Becton, Dickinson and Company, Medtronic plc, Stryker Corporation, Leica Biosystems Nussloch GmbH, Gallini Srl, TSK Laboratory, Remicalm, Meditech Devices, Agilent Technologies Inc., Guardant Health, Inc., Agena Bioscience, nRichDX, Epic Sciences, Inc., Predicine, Inc. , Argon Medical Devices , Cook Medical, Hologic Inc., Gallini Medical, and Intact Medical Corporation.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global biopsy devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biopsy devices market.

Market Segmentation

• Biopsy Devices Market, By Product Type
  • Procedure Tray
  • Needle Based Biopsy Instruments
  • Liquid Biopsy Instruments
  • Biopsy Table
  • Biopsy Forceps
  • Others
• Biopsy Devices Market, By Biopsy Type
  • Bone marrow biopsy
  • Cone biopsy
  • Excisional biopsy
  • Liquid biopsy
  • Needle biopsy
  • Others
• Biopsy Devices Market, By Application
  • Prostate
  • Endometrial
  • Liver
  • Heart
  • Others
• Biopsy Devices Market, By End User
  • Hospitals & Clinics
  • Diagnostic Labs
  • Academic & Research Institutes
• Biopsy Devices Market, By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Company Profiles
  • Merit Medical Systems, Inc.
  • Hologic, Inc.
  • Becton, Dickinson and Company
  • Medtronic plc
  • Stryker Corporation
  • Leica Biosystems Nussloch GmbH
  • Gallini Srl
  • TSK Laboratory
  • Remicalm
  • Meditech Devices
  • Agilent Technologies Inc.
  • Guardant Health, Inc.
  • Agena Bioscience
  • nRichDX
  • Epic Sciences, Inc.
  • Predicine, Inc.
  • Argon Medical Devices
  • Cook Medical
  • Hologic Inc.
  • Gallini Medical
  • Intact Medical Corporation

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Biopsy Devices Market, By Product Type
  • Biopsy Devices Market, By Biopsy Type
  • Biopsy Devices Market, By Application
  • Biopsy Devices Market, By End User
  • Biopsy Devices Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
    • Increasing prevalence of cancer
    • Technological advancements in biopsy devices
    • Government and private funding for cancer research
  • Restraints
    • High cost of biopsy procedures
    • Lack of reimbursement policies
  • Opportunities
• Emerging Economies
• Launch of innovative biopsy gun devices
• Development of minimally invasive biopsy techniques
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Biopsy Devices Market, By Product Type, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Procedure Tray
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Needle Based Biopsy Instruments
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Liquid Biopsy Instruments
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Biopsy Table
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Biopsy Forceps
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Biopsy Devices Market, By Biopsy Type, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Bone marrow biopsy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Cone biopsy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Excisional biopsy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Liquid biopsy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Needle biopsy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Biopsy Devices Market, By Application, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Prostate
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Endometrial
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Liver
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Heart
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Biopsy Devices Market, By End User, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals & Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Diagnostic Labs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Academic & Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Biopsy Devices Market, By Region, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 - 2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2020-2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Mn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (USD Mn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2020-2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Mn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (USD Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2020-2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Mn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (USD Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2020-2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Mn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2020-2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Mn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (USD Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2020-2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Mn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2020 - 2032, (USD Mn)
    • Central Africa
    • South Africa
    • North Africa

9. Competitive Landscape

• Merit Medical Systems, Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hologic, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Becton, Dickinson and Company
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Medtronic plc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Stryker Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Leica Biosystems Nussloch GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Gallini Srl
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• TSK Laboratory
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Remicalm
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Meditech Devices
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Agilent Technologies Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Guardant Health, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Agena Bioscience
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• nRichDX
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Epic Sciences, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Predicine, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Argon Medical Devices
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Cook Medical
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Hologic Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Gallini Medical
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Intact Medical Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us